Mechanism of METTL14-mediated RAD21 mRNA epigenetic transcriptome modification in inhibiting thyroid cancer development.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
48 patients were enrolled.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
METTL14 overexpression inhibited tumor formation in nude mice in vivo. [CONCLUSION] METTL14 inhibits tumorigenesis in TC mice in vivo by mediating m6A modification of RAD21 and decreasing RAD21 mRNA stability.
[OBJECTIVE] This study investigated the mechanism of methyltransferase-like 14 (METTL14)-mediated epigenetic transcriptome modification of RAD21 mRNA in inhibiting thyroid cancer (TC) development.
APA
Ge Y, Qin C, Xiao M (2025). Mechanism of METTL14-mediated RAD21 mRNA epigenetic transcriptome modification in inhibiting thyroid cancer development.. World journal of surgical oncology, 23(1), 434. https://doi.org/10.1186/s12957-025-04024-5
MLA
Ge Y, et al.. "Mechanism of METTL14-mediated RAD21 mRNA epigenetic transcriptome modification in inhibiting thyroid cancer development.." World journal of surgical oncology, vol. 23, no. 1, 2025, pp. 434.
PMID
41239449 ↗
Abstract 한글 요약
[OBJECTIVE] This study investigated the mechanism of methyltransferase-like 14 (METTL14)-mediated epigenetic transcriptome modification of RAD21 mRNA in inhibiting thyroid cancer (TC) development.
[METHODS] TCGA and Starbase databases were used to predict the differential expression of METTL14 in TC tissues. First, 48 patients were enrolled. Immunohistochemistry, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and Western blot (WB) were employed for detecting METTL14 and RAD21 expression levels. The overall RNA N6-methyladenosine (m6A) methylation level was measured using m6A-RNA immunoprecipitation (MeRIP). TC cell lines were transfected with Ad-METTL14 and/or Ad-RAD21, and then detected for proliferation, apoptosis, migration, and invasion using cell count kit-8 assay, flow cytometry, and Transwell assay, respectively. MeRIP-qPCR was adopted to detect the RAD21 m6A modification level. RT-qPCR was applied for detecting RAD21 mRNA stability in actinomycin D-treated cells. RIP was implemented to detect METTL14-RAD21 interaction. Tumor formation assay was performed in nude mice. Tumor weight and volume were recorded. The collected tumor tissues were measured for Ki67-positive cell levels using immunohistochemistry, and METTL14 and RAD21 protein levels using WB.
[RESULTS] METTL14 was notably downregulated and RAD21 was upregulated in TC tissues and cells. METTL14 overexpression inhibited TC cell proliferation, migration, and invasion, and promoted cell apoptosis. METTL14 overexpression reduced RAD21 mRNA stability and inhibited RAD21 expression through m6A modification. RAD21 upregulation caused opposite results to METTL14 overexpression on inhibiting TC cell malignant behaviors. METTL14 overexpression inhibited tumor formation in nude mice in vivo.
[CONCLUSION] METTL14 inhibits tumorigenesis in TC mice in vivo by mediating m6A modification of RAD21 and decreasing RAD21 mRNA stability.
[METHODS] TCGA and Starbase databases were used to predict the differential expression of METTL14 in TC tissues. First, 48 patients were enrolled. Immunohistochemistry, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and Western blot (WB) were employed for detecting METTL14 and RAD21 expression levels. The overall RNA N6-methyladenosine (m6A) methylation level was measured using m6A-RNA immunoprecipitation (MeRIP). TC cell lines were transfected with Ad-METTL14 and/or Ad-RAD21, and then detected for proliferation, apoptosis, migration, and invasion using cell count kit-8 assay, flow cytometry, and Transwell assay, respectively. MeRIP-qPCR was adopted to detect the RAD21 m6A modification level. RT-qPCR was applied for detecting RAD21 mRNA stability in actinomycin D-treated cells. RIP was implemented to detect METTL14-RAD21 interaction. Tumor formation assay was performed in nude mice. Tumor weight and volume were recorded. The collected tumor tissues were measured for Ki67-positive cell levels using immunohistochemistry, and METTL14 and RAD21 protein levels using WB.
[RESULTS] METTL14 was notably downregulated and RAD21 was upregulated in TC tissues and cells. METTL14 overexpression inhibited TC cell proliferation, migration, and invasion, and promoted cell apoptosis. METTL14 overexpression reduced RAD21 mRNA stability and inhibited RAD21 expression through m6A modification. RAD21 upregulation caused opposite results to METTL14 overexpression on inhibiting TC cell malignant behaviors. METTL14 overexpression inhibited tumor formation in nude mice in vivo.
[CONCLUSION] METTL14 inhibits tumorigenesis in TC mice in vivo by mediating m6A modification of RAD21 and decreasing RAD21 mRNA stability.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Methyltransferases
- Animals
- Thyroid Neoplasms
- Mice
- Cell Proliferation
- Apoptosis
- Gene Expression Regulation
- Neoplastic
- RNA
- Messenger
- Epigenesis
- Genetic
- Nude
- Cell Movement
- Female
- Ribonucleoproteins
- Transcriptome
- Male
- Prognosis
- Tumor Cells
- Cultured
- Xenograft Model Antitumor Assays
- M6A
… 외 4개
같은 제1저자의 인용 많은 논문 (5)
- Postoperative recurrence patterns and anatomy-stratified clinical target volume delineation in pancreatic cancer.
- The Burden and Risk Factors of Colorectal Cancer in Older Adults From 2010 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021.
- RT-ICI therapy induces a distal immunometabolic axis that shapes systemic macrophage polarization and enhances local T cell immunity.
- KSR2 functions as a metabolic checkpoint for anti-PD-1 resistance by reprogramming glucose metabolism.
- Role and mechanism of IL-33 in bacteria infection related gastric cancer continuum: From inflammation to tumor progression.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.